AAPG - Ascentage Pharma Corp Revenue Growth YoY (Last 12 Months)

The competent management of Ascentage Pharma Group (AAPG) is effectively developing global alliances and expanding the reach of its innovative oncology ecosystem. This TTM annual sales growth chart visualizes the expansion dynamics, where 69.60 indicates the value of this parameter. Success is based on attracting leading scientists who create cutting-edge methods to combat drug resistance through large-scale R&D investments.
ascentage.com (AAPG) - metric breakdowns and financial figures

This metric measures the rate of revenue change over a rolling year, identifying phases of acceleration or stagnation in commercial flow. By analyzing the 12-month YoY sales change chart on GURU.Markets, an investor assesses demand resilience by comparing current inflows with the same period last year. A negative trend here signals a risk of capital freeze. For Ascentage Pharma Group (AAPG), the dynamics of this metric directly reflect the commercialization efficiency of Olverembatinib and the success of the partnership with Takeda.